Evidence map›Paper›PMID 42515809›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Twenty-Year Trends in Antipsychotic Utilization in Serbia: A Nationwide Drug Utilization Study.

Zorana Pavlovic, Milena Stevanovic, Marija Milic, Jelena Filimonovic, Bojana Matejić, Mladen Bogdanovic, Ivana Vukajlovic, Aleksandar Krstić, Miodrag Milenović, Bojana Dunjić Kostić

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zorana PavlovicClinic for Psychiatry, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0003-7636-306X
Milena StevanovicClinic for Psychiatry, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-9372-2728
Marija MilicDepartment of Epidemiology, University of Pristina Temporarily Settled in Kosovska Mitrovica, 38220 Kosovska Mitrovica, Serbia.ORCID 0000-0001-5575-0587
Jelena FilimonovicDepartment of Epidemiology, University of Pristina Temporarily Settled in Kosovska Mitrovica, 38220 Kosovska Mitrovica, Serbia.ORCID 0000-0002-2161-2394
Bojana MatejićDepartment of Social Medicine, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Mladen BogdanovicNational Center for Drug and Medical Information, Medicines and Medical Devices Agency of Serbia, 11221 Belgrade, Serbia.
Ivana VukajlovicNational Center for Drug and Medical Information, Medicines and Medical Devices Agency of Serbia, 11221 Belgrade, Serbia.
Aleksandar KrstićDepartment of Physiology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.
Miodrag MilenovićFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-4062-3002
Bojana Dunjić KostićClinic for Psychiatry, University Clinical Center of Serbia, 11000 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antipsychotic drugsatypical antipsychoticstypical antipsychoticsutilization

Identifiers

PMID42515809
PMCPMC13414690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.